Combing with the negative clinical correlation found in the frequency of CD8+TIGIT+ T cells and the CD226/TIGIT ratio of CD8+ T cells, TIGIT appears to play a protective role in the development of PBC. This evidence concerns the gene CD226 and primary biliary cholangitis.